Ignite Creation Date:
2024-05-06 @ 3:08 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02213133
Status:
TERMINATED
Last Update Posted:
2023-01-26
First Post:
2014-08-07
Brief Title:
Selinexor Treatment of Advanced RelapsedRefractory Squamous Cell Carcinomas
Sponsor:
Karyopharm Therapeutics Inc
Organization:
Karyopharm Therapeutics Inc
Organization Data
Organization:
Karyopharm Therapeutics Inc
Class:
INDUSTRY
Study ID:
KCP-330-006
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Karyopharm Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None